연구성과로 돌아가기

2021 연구성과별 연구자 정보 (136 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Alleviation of Memory Deficit by Bergenin via the Regulation of Reelin and Nrf-2/NF-κB Pathway in Transgenic Mouse Model Seo, Eun-Kyoung Seo, EK 9 교신저자 Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul 03760, South Korea bushra.shal@gmail.com;adkhan165sbbu@gmail.com;ashrafwazir6@gmail.com;Rphrahimullah@gmail.com;gowhar_ali@uop.edu.pk;dr_ssulman@yahoo.com;ihsn99@yahoo.com;h.ali@qau.edu.pk;yuny@ewha.ac.kr;skhan@qau.edu.pk;
Alleviation of Memory Deficit by Bergenin via the Regulation of Reelin and Nrf-2/NF-κB Pathway in Transgenic Mouse Model Khan, Salman Khan, S 10 교신저자 Quaid I Azam Univ, Fac Biol Sci, Dept Pharm, Pharmacol Sci Res Lab, Islamabad 45320, Pakistan F-4588-2016 Khan, Salman 0000-0002-6226-8470 Khan, Salman bushra.shal@gmail.com;adkhan165sbbu@gmail.com;ashrafwazir6@gmail.com;Rphrahimullah@gmail.com;gowhar_ali@uop.edu.pk;dr_ssulman@yahoo.com;ihsn99@yahoo.com;h.ali@qau.edu.pk;yuny@ewha.ac.kr;skhan@qau.edu.pk;
Alleviation of norflurazon-induced photobleaching by overexpression of Fe-chelatase in transgenic rice Park, Joon-Heum Park, JH 1 Kyungpook Natl Univ, Sch Life Sci, BK21 FOUR KNU Creat BioRes Grp, Daegu 41566, South Korea sjung@knu.ac.kr;
Alleviation of norflurazon-induced photobleaching by overexpression of Fe-chelatase in transgenic rice Jung, Sunyo Jung, S 2 교신저자 Kyungpook Natl Univ, Sch Life Sci, BK21 FOUR KNU Creat BioRes Grp, Daegu 41566, South Korea 0000-0001-6166-9726 Jung, Sunyo sjung@knu.ac.kr;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Ahn, Jae-Sook Ahn, JS 1 Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Ahn, Jae-Sook Ahn, JS 1 Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Jeollanam, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Ahn, Jae-Sook Ahn, JS 1 Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Kim, TaeHyung Kim, T 2 Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada O-4252-2015 Kim, Tae zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Kim, TaeHyung Kim, T 2 Univ Toronto, Dept Comp Sci, Toronto, ON, Canada O-4252-2015 Kim, Tae zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Jung, Sung-Hoon Jung, SH 3 Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Ahn, Seo-Yeon Ahn, SY 4 Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Jung, Seung-Yeon Jung, SY 5 St Carollo Hosp, Dept Hematol Oncol, Jeollanam, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Song, Ga-Young Song, GY 6 Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Kim, Mihee Kim, M 7 Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing Yang, Deok-Hwan Yang, DH 8 Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Gwangju, South Korea zhaolei.zhang@utoronto.ca;hjoonk@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
페이지 이동: